SARS-CoV-2 Envelope antibody (C-Term)
Quick Overview for SARS-CoV-2 Envelope antibody (C-Term) (ABIN7273009)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- anti-Envelope Protein (SARS-CoV-2)
-
Sequence
- MNIVNVSLVK PSFYVYSRVK NLNSSRVPDL LV
-
Specificity
- In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
Cross-Reactivity (Details)
- Reacts with SARS-CoV-2 protein
-
Purification
- Epitope affinity purified
-
Immunogen
- Affinity purified recombinant fusion protein using the C-terminal of Envelope protein (residues 45 to stop) and produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB:1:500-1:2,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 3 mg/mL
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- The antibody solution should be gently mixed before use.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
-
Alternative Name
- Envelope Protein (SARS-CoV-2)
-
Target Type
- Viral Protein
-
Background
-
Envelope (E) is one of the structural proteins of the virus. This protein is a small polypeptide that contains at least one α-helical transmembrane domain and it involved in life cycle of SARS-CoV-2, such as assembly, budding, envelope formation.
ORF4, E SARS Coronavirus-2 antibody.
Target
-